NYSE:SI • US82537J1088
The current stock price of SI is 13.06 USD. In the past month the price decreased by -6.04%.
ChartMill assigns a technical rating of 2 / 10 to SI.
ChartMill assigns a fundamental rating of 3 / 10 to SI. While SI seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SI reported a non-GAAP Earnings per Share(EPS) of -2.5. The EPS decreased by -50.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.03% | ||
| ROE | -31.3% | ||
| Debt/Equity | 0.1 |
13 analysts have analysed SI and the average price target is 21.22 USD. This implies a price increase of 62.45% is expected in the next year compared to the current price of 13.06.
For the next year, analysts expect an EPS growth of -309.2% and a revenue growth -76.23% for SI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.62 | 193.832B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.53 | 169.664B | ||
| SYK | STRYKER CORP | 24.21 | 139.908B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.34 | 109.921B | ||
| BDX | BECTON DICKINSON AND CO | 11.16 | 50.66B | ||
| IDXX | IDEXX LABORATORIES INC | 42.48 | 49.283B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.52 | 44.358B | ||
| RMD | RESMED INC | 20.57 | 35.869B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 35.845B | ||
| DXCM | DEXCOM INC | 27.73 | 25.383B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
SHOULDER INNOVATIONS INC
1535 Steele Avenue Sw, Suite B
Grand Rapids MICHIGAN 92037 US
CEO: Alan J. Lane
Employees: 61
Phone: 16165660286
Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
The current stock price of SI is 13.06 USD. The price decreased by -4.81% in the last trading session.
SI does not pay a dividend.
SI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The Revenue of SHOULDER INNOVATIONS INC (SI) is expected to decline by -76.23% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
SHOULDER INNOVATIONS INC (SI) has a market capitalization of 269.04M USD. This makes SI a Micro Cap stock.